AUG 18, 2026 · PHASE 3 TRIAL
A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
ClinicalTrials.gov
Phase 3 trial with completed recruitment (n=23) examining surrogate immune endpoints in Alzheimer's disease; no results posted in this registry record.
Reported
Planned enrollment23
PhasePhase 3
Primary outcome measure 1Change in Gene Expression Assessed by scRNA…